The Dr Kumar Discovery

Dr Ravi Kumar MD

Welcome to The Dr. Kumar Discovery, a health and wellness podcast hosted by Dr. Ravi Kumar, a board-certified neurosurgeon. This is the medical podcast for anyone who wants honest, evidence-based answers to the health questions that matter most. No corporate influence. Just a physician who reads the research, questions the dogma, and breaks it down in plain language so you can make better decisions about your own health. Dr. Kumar is a practicing neurosurgeon who brings a surgeon's precision to topics most doctor podcasts only scratch the surface of. Each episode dives deep into the science behind metabolic health, cardiovascular disease, heart disease, hormones, nutrition, brain health, mental health, pain, inflammation, weight loss, aging, blood pressure, sleep, and longevity. Whether it's the truth about seed oils, the real data on GLP-1 drugs and weight loss, the science of cold water therapy, how light can heal the body, or why your testosterone is declining, Dr. Kumar goes straight to the peer-reviewed literature and tells you what the evidence actually shows, not what the headlines say. This is evidence-based medicine in plain English. The show features three formats. Solo deep dives explore a single health topic from the ground up, covering everything from the biology to the practical takeaways you can use today. Expert interviews bring on leading researchers, clinicians, and forward-thinking voices in health and medicine for in-depth conversations you won't hear anywhere else. The Tribulations series tells the true stories behind medicine's greatest breakthroughs, from the discovery of penicillin to the invention of vaccines to a father's fight to save his son's life. These are the stories of the doctors, scientists, and patients who changed the course of medicine. Topics covered on the show include testosterone and hormone optimization, sleep science, photobiomodulation and red light therapy, exercise with oxygen therapy, creatine, uric acid and gout prevention, gut health and probiotics, cardiovascular risk and Lp(a), cholesterol, PANDAS in children, PTSD and trauma, acetaminophen safety, glyphosate, foot health, and much more. If you're tired of generic health advice and want to hear from a neurosurgeon who actually reads the studies, The Dr. Kumar Discovery is your podcast. New episodes drop regularly. Subscribe and join the discovery. For show notes, references, and more, visit drkumardiscovery.com/podcast

  1. 8h ago

    The Science of APOE4: Why Evolution Kept the Alzheimer's Gene

    Every year more people get their DNA tested, and a lot of them find out they carry a gene called APOE4, the so called Alzheimer's gene. Today Dr. Ravi Kumar takes it apart, because he carries a copy himself, and the standard story about it never quite added up to him. Ravi builds the case with real data. In the Tsimane of the Bolivian Amazon, a 2017 study of 372 people found something backwards from what you'd expect: APOE4 carriers with a heavy parasite burden held onto their cognition while non-carriers declined, and a separate study of nearly 800 Tsimane women found carriers had more children, born earlier and spaced closer together. The gene also runs a quieter baseline immune system that fires harder the moment a real threat shows up, which was useful when infection, not old age, was the thing most likely to kill you. None of that makes APOE4 harmless today. The famous odds ratio of 14.9 doesn't mean two copies makes someone 15 times more likely to get Alzheimer's, the number that actually applies to your life is lifetime risk, which by 85 runs around 51 percent for men and 60 percent for women with two copies. Nearly everyone with two copies develops the amyloid and tau pathology under the microscope, yet roughly four in ten still reach 85 with a clear mind. Ravi carries one copy himself, and the standard message about it, honestly, never sat right with him. His answer isn't to dismiss the risk, it's to reframe it: two copies raises your risk substantially, but it does not decide your outcome. The rest of the episode is what to actually do with that reframe: protecting deep sleep, since even one lost night has been shown to raise amyloid in the brain, treating hearing loss, which is one of the few dementia interventions backed by a randomized trial instead of just correlation, and guarding insulin sensitivity and blood pressure specifically in your 40s and 50s, the exact window where the data shows the damage compounding. What You'll Learn APOE4 Is The Ancestral Version: Comparing human DNA to chimpanzee DNA shows the chimp version of the gene lines up closest with APOE4, which suggests E3 and E2 are the newer variants and E4 is the original form our lineage carried.Odds Ratio Is Not Lifetime Risk: The widely cited 14.9 odds ratio from a 1997 JAMA meta-analysis does not mean two copies makes you 15 times more likely to develop Alzheimer's, the number that actually maps onto your life is lifetime risk.Four In Ten Reach 85 Untouched: Even with two copies of APOE4, roughly four in ten men and four in ten women reach age 85 without ever developing Alzheimer's disease.Pathology Is Not Dementia: Nearly every person with two copies of APOE4 develops the amyloid plaques and tau tangles visible on brain scans, yet about half of them still reach 85 with a clear, strong mind.The Parasite Flip In The Tsimane: A 2017 study of 372 Tsimane found APOE4 carriers without much parasite exposure recalled fewer words than non-carriers, but among those with a heavy parasite burden the pattern flipped and APOE4 carriers held their cognition while non-carriers declined.APOE4 And More Children: A 2023 study of 795 Tsimane women found carrying APOE4 was linked to more children, earlier first births, and shorter gaps between pregnancies.The Smoke Detector Immune System: In the Tsimane, APOE4 carriers ran about 30 percent lower baseline inflammation but mounted a stronger immune response the moment a real threat appeared, quiet until there's an actual fire.Hearing Aids Cut Cognitive Decline: The randomized ACHIEVE trial, published in The Lancet in 2023, found hearing aids cut the rate of cognitive decline roughly in half among older adults already at higher risk, one of the few dementia interventions backed by a controlled trial rather than an association.One Night Of Lost Sleep Raises Amyloid: A 2018 study that kept 20 healthy adults awake for a single night found amyloid rose about 5 percent in the thalamus and hippocampus, the areas the glymphatic system is supposed to be clearing while you sleep.Diabetes Plus APOE4 Multiplies Risk: A 2002 study found that having type 2 diabetes on top of carrying APOE4 raised relative risk 5.5 times compared with having neither, making insulin sensitivity one of the clearest gene-environment interactions in the literature.Selection Had No Leverage At 80: Among the Hadza hunter-gatherers, only about 8 of every 100 births reached age 80, so a gene that only causes harm that late in life was nearly invisible to natural selection while its fertility and infection benefits acted on everyone.Midlife Blood Pressure Doubles Risk: A 2001 BMJ study following nearly 1,500 people for decades found high blood pressure in your 40s and 50s roughly doubled later Alzheimer's risk, and high midlife cholesterol on top of it more than tripled the risk.Episode Highlights: [00:00:00] Would evolution really keep a bad gene?[00:02:14] Why Ravi is making this episode[00:04:19] Disclaimer and what APOE actually is[00:06:32] Astrocytes, microglia and the fat-immune link[00:08:24] Liver receptors, LDL and amyloid clearance[00:10:35] Pathology is not the same as dementia[00:12:42] Lifetime risk by copies and by sex[00:15:10] The Tsimane and the parasite burden flip[00:17:12] Shantytown children and early illness[00:19:27] The ancestral bargain, billed decades later[00:21:50] Why selection had no leverage in late life[00:24:07] Ultra-processed food and metabolic syndrome[00:26:10] Amyloid, tangles and the glymphatic system[00:28:30] Midlife cholesterol and obesity[00:30:58] Hearing loss, the ACHIEVE trial and isolation[00:32:51] Vision loss, smoking and depression[00:35:07] Air pollution, and defect versus mismatch[00:37:23] A risk factor, not a verdictEpisode Resources: Dr. Ravi Kumar's WebsiteThe Dr. Kumar Discovery on YouTubeThe Dr. Kumar Discovery on Apple PodcastsThe Dr. Kumar Discovery on SpotifyThe Dr. Kumar Discovery on InstagramThe Dr. Kumar Discovery on XThe Dr. Kumar Discovery on TikTokThe Dr. Kumar Discovery on FacebookDr. Ravi Kumar on LinkedIn

    The Science of APOE4: Why Evolution Kept the Alzheimer's Gene
  2. Sep 1

    The Science of Metabolic Psychiatry: How Ketones Feed a Starving Brain | Dr. Matt Bernstein

    If you're new here, do me a favor and hit subscribe, and if this episode gives you something to chew on, a quick review helps more people find the show. Today's conversation is one of the most eye-opening we've done on the link between diet and severe mental illness. Here's a claim that sounds almost too big to believe: in a small pilot trial at Stanford, everyone with schizophrenia or bipolar disorder who stayed fully adherent to a ketogenic diet went into remission from their mental health disorder. Not improved. Remission. Dr. Matt Bernstein is quick to qualify what that does and doesn't mean, but the underlying idea, that severe mental illness is in part a brain energy problem, is one mainstream psychiatry has barely begun to reckon with. Dr. Matt Bernstein is a traditionally trained psychiatrist who spent years on inpatient units treating psychosis, severe mania, and catatonia with medications and ECT. Around 2010 he moved into psychosocial rehabilitation and came to believe that medications, while they stabilize people short term, can sometimes get in the way of long-term functional recovery. He now runs Accord, an immersive metabolic psychiatry program outside of Boston, where a chef, dietitian, personal trainer, and social worker help patients use diet and lifestyle to treat serious mental illness. Bernstein's own path into this field started close to home. Around 2017, two of his three sons developed sudden, severe OCD, depression, and cognitive symptoms that turned out to be a form of autoimmune encephalitis. Not long after, he sat in a grand rounds lecture by Dr. Chris Palmer at McLean Hospital, a colleague he knew from residency, and says he may have been the only person in a room of about 150 who walked out fully convinced. He put himself on a ketogenic diet before ever prescribing it, and in retrospect believes he'd been insulin resistant himself. That personal experiment became the seed of Accord. The biology centers on brain regions like the hypothalamus, hippocampus, and amygdala, which depend on insulin to pull in fuel. When those regions turn insulin resistant, the neurons that govern mood, memory, and anxiety start starving even while glucose is plentiful everywhere else. Ketones sidestep that problem, diffusing into cells without needing an insulin signal at all. Ravi and Bernstein walk through the evidence, including Dr. Shivani Sethi's Stanford pilot and a French inpatient series with effect sizes far beyond what antidepressants or antipsychotics typically show against placebo, while flagging clearly that both are single-arm trials with no control group. They also cover what the diet looks like day to day, the three month commitment it takes to know if it's working, and why it only works as part of a broader package of exercise, sleep, sunlight, and medical supervision. Episode Resources Accord - Dr. Bernstein's ClinicDr. Bernstein's LinkedInDr. Ravi Kumar's WebsiteThe Dr. Kumar Discovery on YouTubeThe Dr. Kumar Discovery on Apple PodcastsThe Dr. Kumar Discovery on SpotifyThe Dr. Kumar Discovery on InstagramThe Dr. Kumar Discovery on XThe Dr. Kumar Discovery on TikTokThe Dr. Kumar Discovery on FacebookDr. Ravi Kumar on LinkedInIn this episode, you will discover Some brain regions, like the hypothalamus, hippocampus, and amygdala, rely on insulin to pull glucose into their cells, so when those regions turn insulin resistant, the neurons literally start running out of fuel.Ketones bypass that insulin gate entirely, diffusing straight into cells and delivering what Bernstein calls an immediate rescue to exactly the brain regions that govern mood, memory, anxiety, and psychosis.In a small single-arm pilot at Stanford led by Dr. Shivani Sethi, every patient with schizophrenia or bipolar disorder who stayed fully adherent to the ketogenic diet reached remission, alongside reversed metabolic syndrome markers.A 2022 French inpatient series of about 31 patients found effect sizes above 3 on standard psychiatric scales, compared to roughly 0.35 for SSRIs and 0.5 to 0.6 for antipsychotics against placebo.Bernstein tells patients they need to stay in ketosis for about three months before they can really know if it's working, and says he has yet to see someone reach that mark and feel nothing.Ketones activate a pathway called PGC-1 alpha that drives the growth of new mitochondria, which Bernstein thinks may matter even more than the fuel switch itself, and why some patients keep improving well past the one year mark.Ketones also turn on the gene for brain-derived neurotrophic factor, producing a more flexible, adaptable brain, which Bernstein calls the actual definition of mental health.Ketogenic ratios are measured in grams of fat to grams of protein and carbs combined, and while the original 1921 epilepsy diet used a 4:1 ratio, Bernstein usually starts patients at 1:1.Unlike the classic epilepsy version of the diet, Bernstein deliberately keeps protein high, because signals released from working muscle act as a growth signal the brain can pick up on.A single ketone reading can be misleading since beta-hydroxybutyrate can swing tenfold in a day, so Bernstein cares more about how a patient is actually doing than one afternoon fingerstick number.On a continuous glucose monitor, one patient's blood sugar spiked from a flat 60 to 90 line up to 140 purely from a panic-inducing phone call, and came back down within five minutes of slow breathing.Studies suggest a whole-foods ketogenic diet, built around things like ground beef, cheese, and onions, can be done on food stamps, so cost isn't the automatic barrier people assume.Episode Highlights [00:00:00] Cold open: your brain runs on energy[00:03:27] What metabolic psychiatry actually is[00:08:44] Why psychiatry ignores the rest of the body[00:10:38] The 1921 keto diet and pediatric epilepsy[00:15:26] The forgotten 1960s schizophrenia study and Chris Palmer[00:19:48] Convincing the first patients to change their diet[00:23:59] Ketogenic ratios, from 4:1 down to 1:1[00:27:11] Why one ketone reading can mislead you[00:30:29] Gluconeogenesis and protecting glucose[00:35:11] UCSF and UK randomized trials[00:37:25] Exercise for depression: effective but hard to deliver[00:43:12] Children, and what he wishes he had known[00:46:35] Insulin resistant brain regions and starving neurons[00:50:44] Mitochondrial dysfunction and PGC-1 alpha[00:54:00] Can you cycle in and out of ketosis?[00:57:04] When the body looks metabolically healthy[01:01:30] The microbiome, sterile mice and Akkermansia[01:05:43] Do exogenous ketones work?[01:10:49] Lithium, diuresis and electrolytes[01:13:28] Type 2 diabetes is reversibleKey Takeaways If you o...

    The Science of Metabolic Psychiatry: How Ketones Feed a Starving Brain | Dr. Matt Bernstein
  3. Aug 25

    The Cancer Add-On Therapies Most Oncologists Never Mention | Dr. Casey Peavler

    What if cancer is better understood as a metabolic and mitochondrial disease than a purely genetic one? In this episode, Dr. Ravi Kumar talks with a hospitalist who has spent years digging into the metabolic science of cancer about the idea that mitochondrial dysfunction may actually come first, as a precursor to the genetic abnormalities we associate with tumors, and what that reframing opens up for patients already in treatment. Doctor Peavler is a hospitalist by day who began offering integrative consults to cancer patients a little less than two years ago. He was a flight surgeon in the Air Force, where he took hyperbaric medicine courses, and he now runs a science-heavy YouTube channel with over 200 long-form videos. He takes consults from people all over the world and is upfront that he loses many of them to follow-up, which means he can't claim outcomes data the way a formal trial could. The two dig into the press-pulse framework: a chronic "press," like a therapeutic ketogenic diet paired with mind-body stress reduction, meant to lower glucose, insulin, glucocorticoids and catecholamines over time, combined with intermittent "pulses" delivered when a tumor is already weakened. The logic rests on a quirk of cancer biology. Normal cells with healthy mitochondria and enough oxygen can switch fuels as needed, but cancer cells with damaged mitochondria and hypoxia are stuck relying on glucose and glutamine, the same two fuels that supply most of the NADPH a cell needs to defend itself against oxidative stress. On the pulse side, they cover high dose IV vitamin C, which works less as an antioxidant and more as a pro-oxidant that reacts with extracellular iron to generate free radicals inside iron-hungry tumor cells, and hyperbaric oxygen, which dissolves oxygen into plasma rather than just topping off hemoglobin, letting it reach the hypoxic pockets a tumor's leaky vessels can't. They also get into repurposed drugs like metformin, mebendazole, and ivermectin, and why glutamine, the most abundant amino acid in the blood, is nearly impossible to starve through diet alone. Doctor Peavler is candid throughout: this is an emerging field, he doesn't believe in one magic bullet, and everything discussed is meant to be brought to an oncologist, never used in place of one. Episode Resources Dr. Peavler's YouTube channelDr. Peavler's Educational CourseDr. Peavler's WebsiteDr. Peavler's InstagramDr. Ravi Kumar's WebsiteThe Dr. Kumar Discovery on YouTubeThe Dr. Kumar Discovery on Apple PodcastsThe Dr. Kumar Discovery on SpotifyThe Dr. Kumar Discovery on InstagramThe Dr. Kumar Discovery on XThe Dr. Kumar Discovery on TikTokThe Dr. Kumar Discovery on FacebookDr. Ravi Kumar on LinkedInIn this episode, you will discover Mitochondrial dysfunction may be the precursor to the genetic abnormalities we see in cancer, not simply a downstream effect of them.Antioxidant-rich diets may help prevent cancer, but once cancer is present, antioxidants like NAC appear to worsen prognosis, disease control, and mortality."Press" interventions are done chronically, like a therapeutic ketogenic diet and stress reduction, while "pulse" interventions are delivered intermittently to hit a tumor when it is vulnerable.Normal cells with working mitochondria can switch fuels, but cancer cells with damaged mitochondria and low oxygen are locked into relying on glucose and glutamine.High dose IV vitamin C acts as a pro-oxidant, reacting with extracellular iron to generate free radicals before entering cells through the GLUT1 transporter.About 80 percent of the NADPH a cell uses to power its antioxidant defenses comes from glucose and glutamine metabolism, so cutting those fuels also strips away a cancer cell's defenses.Hyperbaric oxygen works by dissolving far more oxygen into plasma, not by pushing hemoglobin saturation a couple points higher, which lets it reach hypoxic pockets inside a tumor.Glutaminase may be the most important enzyme in glutaminolysis, since the glutamate it produces feeds fatty acids, nucleotides, other amino acids, energy production, and glutathione.Cancer cells import iron at a much higher rate than normal cells and export less of it, making them especially vulnerable to a form of cell death called ferroptosis.Dosing and infusion rate both matter for IV vitamin C, with expert dosing around 0.5 to 1.5 grams per kilogram and the same total dose spread over 24 hours likely not producing the same effect as a shorter infusion.The glucose ketone index compares blood glucose to ketones to gauge depth of ketosis, with a hard goal of one and a softer, continuous goal of under two.Mebendazole appears to do more than block microtubules, also downregulating glucose transporters and reducing glutaminase expression by 50 to 60 percent at achievable doses.Glutamine is the most abundant amino acid in the bloodstream and can't be meaningfully lowered through diet, so the strategy shifts to hitting several nodes of the system at once.A preclinical ovarian cancer paper showed ivermectin downregulating key glutamine and glucose metabolism enzymes by upwards of 70 percent, though side effects like transient eye floaters showed up in roughly 30 to 50 percent of people at decent doses.Episode Highlights [00:00:00] Cold open and the cancer disclaimer[00:03:52] Is cancer a metabolic disease?[00:08:38] Dogma, career risk, and swimming upstream[00:11:44] Introducing the press pulse framework[00:12:51] What counts as a press[00:15:30] Glycolysis intact, oxphos broken[00:20:03] Who reaches ketosis fast and who does not[00:23:17] Attacking glutaminolysis as a system[00:26:34] Thickening the plot with NADPH and redox[00:29:43] The two pulse tools[00:32:25] Doubling survival in pancreatic cancer[00:35:58] The hydroxyl radical nobody talks about[00:40:23] Dissolved plasma oxygen reaches the tumor[00:43:30] The ecology analogy behind press pulse[00:45:20] Ivermectin, politics, and asking the question[00:49:25] Crossing the blood brain barrier in glioblastoma[00:52:11] Pharmaceutical grade only, with a doctor[00:55:54] An honest accounting of what he has seen[00:59:15] The channel, consults, and community[01:03:02] Question everythingKey Takeaways Nothing here is medical advice, and every therapy discussed, from ketogenic metabolic therapy to IV vitamin C, hyperbaric oxygen, and repurposed drugs, is framed as a potential add-on to be worked through with an oncologist, never a replacement for chemotherapy or standard treatment. The antioxidant question actuall...

    The Cancer Add-On Therapies Most Oncologists Never Mention | Dr. Casey Peavler
  4. Aug 18

    Can You Prevent a Heart Attack Before it Happens? | Dr. John Osborne, MD

    If you're new here, do me a favor and hit subscribe, and if you've got a minute, leave a review. It helps more people find conversations like this one, where we dig into the stuff that actually changes how you think about your own health. Here's something that should stop you: put a hundred people with no symptoms into a modern cardiac CT with AI plaque analysis, and only about one percent come out completely clean. Roughly a third of first-timers are already sitting in the most severe stage of plaque buildup, the stage where the ten-year odds of a heart attack or stroke run about forty percent if nothing changes. Most of those people have normal cholesterol panels, normal stress tests, and no idea anything is wrong. In this episode Ravi sits down with Dr. John Osborne, a preventative cardiologist who has spent thirty years working to catch heart disease before it ever causes a symptom. He's Harvard trained, holds a PhD in cardiovascular physiology, and has been doing cardiac CT for about twenty five years, putting him among the earliest adopters of the technology. He now runs Clear Cardio, a telecardiology practice built around cardiac CT and AI plaque analysis, licensed in more than 35 states. The tool most people know is the calcium score, and Osborne is clear that it's not a bad test, just an incomplete one. It only sees calcified plaque, the hard, inert "extinct volcano" left behind after an event, and depending on the population, ten to fifty percent of people with a zero score are still carrying significant lipid-rich plaque the scan simply can't see. That soft plaque is the "lava," the kind that grows quietly for years and then ruptures. Cardiac CT paired with AI changes that picture. It reveals plaque that was previously invisible, measures it in cubic millimeters, and lets doctors track the same plaque over time to see whether it's growing or shrinking. Osborne walks through the staging system, plaque volume graded one to three, with stage three starting at 750 cubic millimeters and carrying that forty percent ten-year event rate. What surprised Ravi most is how little any of this tracks with cholesterol numbers. Across hundreds of thousands of AI exams, Osborne says there's no correlation between plaque burden and LDL, ApoB, or Lp(a), illustrated by two patients with an identical LDL of 108, one with zero plaque and the other with a volume of 1640. The good news is that plaque isn't a one-way street. With a personalized plan covering lipids, blood pressure, and tobacco use, Osborne sees ten to twenty percent reversal within a couple of years, sometimes as much as fifty. Episode Resources Clear Cardio websiteClear Cardio YouTube ChannelDr. Ravi Kumar's WebsiteThe Dr. Kumar Discovery on YouTubeThe Dr. Kumar Discovery on Apple PodcastsThe Dr. Kumar Discovery on SpotifyThe Dr. Kumar Discovery on InstagramThe Dr. Kumar Discovery on XThe Dr. Kumar Discovery on TikTokThe Dr. Kumar Discovery on FacebookDr. Ravi Kumar on LinkedInIn this episode, you will discover Depending on the population studied, anywhere from ten to fifty percent of people with a zero calcium score still have significant lipid-rich plaque that the scan cannot see.Calcified plaque is the inert "extinct volcano" left after an eruption, while the dangerous plaque is the lipid-rich soft "lava" that grows, ruptures, and causes heart attacks and strokes.Quantitative AI on cardiac CT reveals plaque that was previously invisible, measures it in cubic millimeters, and tracks the same plaque over time to show growth or regression.With a customized plan, ten to twenty percent plaque reversal in a couple of years is common, and Osborne has seen up to fifty percent, against a background progression rate of about ten percent a year if nothing is done.Lipids are a risk factor, but plaque itself is the disease, so the first question is always whether disease is actually present in your vessels.Across hundreds of thousands of AI exams, there is no correlation between plaque burden and LDL, non-HDL, ApoB, or Lp(a), illustrated by two patients with an identical LDL of 108 and totally different plaque volumes.On high-end equipment, the cardiac CT radiation dose is about twenty percent of a mammogram, for a disease that kills roughly ten times more women than the cancer mammograms screen for.Quitting tobacco of any kind cuts cardiovascular event risk by about fifty percent within a year, before any cholesterol treatment, diet, exercise, or weight loss.Total plaque volume is graded stage one to three, and stage three, which starts at 750 cubic millimeters, carries a forty percent ten-year risk of a stroke or heart attack if untreated.Osborne argues that starting with a low-dose combination of two or more cholesterol drugs lowers cholesterol better and with fewer side effects than pushing a single statin higher and higher.The first oral PCSK9 inhibitor was approved the day before this recording, delivering the same LDL and Lp(a) lowering as the injectable versions with side effects Osborne calls close to placebo.Stress tests are essentially useless for catching early disease, and about a third of Osborne's stage three patients feel completely fine with a normal stress test.Nicotine receptors on the vessel lining, in any form of tobacco including vapes and pouches, turn the artery wall from Teflon into Velcro.There is a third, rarer plaque type called low density noncalcified plaque, and when it shows up it is a major risk factor for rupture.Episode Highlights [00:00:00] Intro: looking inside your arteries before symptoms[00:02:32] What preventative cardiology actually is[00:06:40] Inside the scanner: the one-second scan[00:08:30] Hard plaque, soft plaque and the lava[00:13:22] Do you still do calcium scans?[00:17:31] The woman with a zero score who had a heart attack[00:19:34] Risk versus benefit against the mammogram[00:21:34] Plaque volume, the three stages and event rates[00:25:01] The couple of forty two years with identical LDLs[00:27:55] ApoB of 180 at 48 with zero plaque[00:31:09] Implementation lag and the Wayne Gretzky approach[00:34:35] Lipids at the scene of the crime, plus risk enhancers[00:38:20] Statins, side effects and the wider toolbox[00:42:18] Hitting the target with the right combination first[00:44:17] Practising off randomised trial evidence[00:46:55] The goal of eliminating heart disease[00:51:34] The same drug that cuts PVCs by sixty percent[00:55:07] Mediterranean, DASH and eggs as health food[00:58:44] Where to find Clear Cardio and its videos[01:00:40] Stress tests are absolutely uselessKey Takeaways The real lesson here is to ask whether you actually have the disease before you argue...

    Can You Prevent a Heart Attack Before it Happens? | Dr. John Osborne, MD
  5. Aug 11

    Alpha Lipoic Acid: Real Help for Diabetic Nerve Pain and Aging Mitochondria

    Somewhere in a lab, two old rats started moving around their cage like they had their youth back, and the molecule behind it is sitting on pharmacy shelves everywhere: alpha lipoic acid. In this solo deep dive, Dr. Ravi Kumar goes to the actual literature to find out what this supplement really does inside your cells. Here is the detail that breaks the simple antioxidant story. Oral alpha lipoic acid has a half life of about thirty minutes and is essentially cleared from your blood in ninety, yet its effects can last for days or weeks. That mismatch is the clue. A brief oxidative nudge from the molecule appears to switch on NRF2, a master regulator that turns on hundreds of your own genes for antioxidants, detoxification, and repair, work that keeps going long after the lipoic acid itself is gone. Unlike vitamin C, we never lost the ability to make this molecule ourselves, an enzyme called lipoic acid synthase builds it inside our mitochondria, where it is bolted onto the machinery that turns food into energy. That production capacity fades with age and metabolic stress, which is why lipoic acid is called conditionally essential. The clearest human evidence is in diabetic neuropathy, where trials going back to ALADDIN in 1995 and the Sydney trial support 600 milligrams a day of the R form for easing burning and tingling, taken on an empty stomach so food does not blunt absorption. Ravi is careful to size the rest of the evidence honestly. Weight loss effects are real but modest, nowhere near what newer medications can do, and the dancing-rat rejuvenation study was in rats, not people. He also flags real cautions: lipoic acid can stack with glucose-lowering drugs, and in genetically susceptible people, especially those of East Asian descent, it carries a rare risk of insulin autoimmune syndrome. His bottom line is that it reduces the damage from diabetes without fixing diabetes itself, and for most people the better first move is protecting their own production with movement and real food. What You'll Learn The Molecule Is A Signal, Not A Scrubber: Lipoic acid's benefit seems to come less from personally neutralizing free radicals and more from acting as a tiny controlled stress that switches on your own defense genes.Ninety Minutes Versus Weeks: Oral lipoic acid has a half life of about thirty minutes and is essentially cleared from the blood in ninety, yet its effects can persist for days or weeks, which is the clue that it works as a signal rather than a direct chemical fix.NRF2 Is The Defense Foreman: A brief oxidative nudge from lipoic acid activates NRF2, which switches on hundreds of your own genes for antioxidants, detoxification, and repair that keep working long after the molecule itself is gone.Your Body Already Makes It: Unlike vitamin C, humans never lost the ability to make lipoic acid, an enzyme called lipoic acid synthase builds it from scratch inside your mitochondria.The Swinging Arm On The Furnace Door: Lipoic acid is the arm on pyruvate dehydrogenase that physically passes fuel into the Krebs cycle, making it essential for turning food into energy.Conditionally Essential With Age: Your ability to make lipoic acid declines as mitochondria decline with age, disease, and metabolic stress, which is what makes it conditionally essential rather than always essential.Diabetic Neuropathy Is The Strongest Evidence: Randomized trials starting with ALADDIN in 1995 and the Sydney trial support 600 milligrams a day for reducing burning and tingling, and Germany has approved it as thioctic acid for decades.The R Form Matters: Cheap supplements are often a fifty-fifty mix of the natural R form and a synthetic S form your body does not use well, so look for R lipoic acid, R alpha lipoic acid, R-LA, or sodium R lipoate.AMPK, The Exercise Impersonator: Lipoic acid flips the same cellular fuel gauge that fasting and exercise flip, telling muscle and liver to burn fat, take up sugar, and build more mitochondria.Two Sulfurs, One Rare Risk: The reactive sulfur pair in lipoic acid can trigger insulin autoimmune syndrome, also called Hirata disease, in genetically susceptible people, a risk that is much more common in people of East Asian descent.The Antioxidant Network: In its reduced form, lipoic acid recharges spent vitamin C and vitamin E and regenerates glutathione and coenzyme Q10, sitting one rung up the ladder from the other antioxidants.Food Blunts Absorption: Lipoic acid works best taken on an empty stomach thirty to sixty minutes before a meal, and doses above 600 milligrams tend to cause nausea.Episode Highlights: [00:00:00] Old rats dancing the Macarena[00:02:27] Going to the literature and finding it backwards[00:04:44] Why we never lost the gene, unlike vitamin C[00:06:45] Chloroplasts, spinach and broccoli[00:08:41] Recharging the antioxidant network[00:10:56] Exercise and vaccines as controlled stress[00:12:49] Ampk and impersonating fasting[00:15:04] Aladdin, Sydney and the six hundred milligram dose[00:17:24] Sizing the weight loss data honestly[00:19:37] Should you take it: form, timing and dose[00:22:03] Hirata disease and East Asian ancestry[00:24:17] Lifestyle first, supplement as a small assistEpisode Resources: Dr. Ravi Kumar's WebsiteThe Dr. Kumar Discovery on YouTubeThe Dr. Kumar Discovery on Apple PodcastsThe Dr. Kumar Discovery on SpotifyThe Dr. Kumar Discovery on InstagramThe Dr. Kumar Discovery on XThe Dr. Kumar Discovery on TikTokThe Dr. Kumar Discovery on FacebookDr. Ravi Kumar on LinkedIn

    Alpha Lipoic Acid: Real Help for Diabetic Nerve Pain and Aging Mitochondria
  6. Aug 4

    Build Muscle, Increase Strength, & Improve Recovery | Blood Flow Restriction Exercise

    What if you could get close to the strength and muscle gains of heavy lifting using nothing but a resistance band, a water bottle, and a set of cuffs? Restricting blood flow during light exercise turns out to produce strength gains roughly on par with training at heavy loads, and the muscle under the cuff can desaturate down to 5 to 10 percent oxygen, which is about as intense as exercise physiology gets. In this episode, Dr. Kumar sits down with Sten Stray Gunderson, an assistant professor at the University of South Carolina who has spent more than a decade studying hypoxia and exercise physiology. Blood flow restriction training runs in the family: his father, Dr. Jim Stray Gunderson, helped pioneer the field and developed Be Strong, the only BFR cuff built by a medical doctor. Sten used BFR himself as a soccer player, and once spent about six months sleeping, eating, and doing homework in a hypoxia tent as a competitive cross country skier. The mechanism comes down to which blood vessels the cuffs are damming. Positioned high on the arms or legs, they restrict venous outflow while arterial inflow keeps working, so metabolites pool inside the muscle instead of clearing. That accelerated fatigue lets a load as light as 20 to 30 percent of your max recruit the same high threshold, fast twitch motor units that normally require heavy weight. Sten points to a seminal 2000 study in older women doing bicep curls: the heavy load group and the BFR group ended up with equal gains in force production, while the light load group without cuffs barely improved at all. They also dig into what makes a session actually work and where the real risk lies. The target is a genuine fatigue pocket, three to five sets of fifteen to twenty reps with the last five a real struggle, cuffs staying inflated between sets, and effort against proximity to failure sitting at the top of the hierarchy Sten laid out in his own review paper, with cuff pressure at the bottom. They cover why decades of Katsu use in Japan show very few complications, why BFR may lower clotting risk rather than raise it, and how the effects reach beyond the cuffed limb, to muscles above it, to VO2 max and muscle size rising together, and to a possible link between BFR generated lactate and brain fuel. Episode Resources BStrong WebsiteDr Sten Stray-Gunderson PhD, CSCSDr. Ravi Kumar's WebsiteDr. Ravi Kumar on LinkedInIn this episode, you will discover The adaptation comes from damming venous outflow, not cutting off arterial inflow, since true arterial occlusion risks ischemia and muscle damage.Accelerated fatigue under restriction lets loads of just 20 to 30 percent reach the high threshold motor units that normally require heavy weight.A seminal 2000 study in older women found equal strength gains between the heavy load group and the BFR group, while the light load group barely improved.The real trigger is three to five sets of fifteen to twenty reps where the last five reps are a genuine struggle, with the discomfort coming from the muscle, not the band.In Sten's own review paper, perception of effort and proximity to failure sit at the top of the hierarchy, with cuff pressure at the bottom.Cuffs go high, where the deltoid meets the bicep or the hamstring meets the glute, never at the elbow, knee, or calf.Decades of Katsu use in Japan, with tens of thousands of daily sessions, show very rare complications, and sickle cell disease is the one absolute contraindication.Because the muscle pump prevents blood stasis and BFR raises tPA and nitric oxide, the technique may actually lower clotting risk rather than raise it.Keeping the cuffs inflated between sets, resting just thirty to sixty seconds, is what keeps the muscle in that fatigue pocket.Local muscle hypoxia from BFR shares the HIF-1 alpha and VEGF pathway with altitude training, but it doesn't stimulate EPO the way sustained altitude living does.Muscles above the cuff, like the pecs and lats, grow too, through greater reliance on unrestricted muscles and a systemic anabolic response.Aerobic BFR studies, including treadmill walking in a clinical population and uphill walking in basketball players, showed VO2 max and quadriceps size increasing together.mTOR and growth hormone rise as if a major insult occurred, but because the actual mechanical work was light, there's little tissue to repair, so the signaling upgrades the system for 48 to 72 hours.All you really need is body weight squats, lunges, glute bridges, wall push ups, water bottle curls, and a cheap set of resistance bands.Episode Highlights [00:00:00] Why light loads can build real muscle[00:08:13] What the cuffs look like and where they go[00:12:54] How a semi elastic cuff prevents occlusion[00:16:08] Where BFR fits for elite athletes[00:24:01] Hotel gyms, new babies and deload weeks[00:29:36] Reaching failure at much lower loads[00:37:18] VO2 max, mitochondria and muscle size together[00:41:31] Safety data and why DVT risk may drop[00:49:30] Should everyone own a pair of bands[00:54:59] Neurological adaptation explained[01:01:14] Motor unit recruitment and the size principle[01:09:59] Hypoxia inducible factor and VEGF[01:14:40] Altitude tents versus local muscle hypoxia[01:19:06] Nitric oxide, shear stress and two pathways[01:27:45] Clearing lactate after a session[01:33:25] Exercise as an essential nutrient[01:38:02] The U shaped hormetic curve[01:45:15] Why muscles above the cuff also grow[01:53:04] Protocol for adding arm hypertrophy[01:57:07] Body weight and resistance band exercise listKey Takeaways Heavy loads are still the gold standard for building strength and size, but BFR gives you a way to keep stimulating those same adaptations on light days, deload weeks, travel days, or the days you're simply too tired for a full session. The band isn't doing the work for you: you still have to push into real muscular discomfort, because it's the conscious effort and proximity to failure that trigger the adaptation, not the cuff itself. For deconditioned or older people, Sten recommends starting small, one to three exercises, three sessions a week, adding one exercise per week before ever touching sets, weight, or pressure. Because the loads are light, you can also drill perfect technique and engage stabilizing muscles without the compensations that heavy weight tends to force. BFR is a hormetic stressor, and like any hormetic stressor it only pays off when sleep, nutrition, and adequate substrate are already in place, and the most striking responses Sten has seen are in clinical populations who couldn't exercise before, showing up in mood and general well being as much as in muscle. Maybe the real value is just lowering the barrier to entry: a five minute session on a day you'd otherwise skip still delivers the therapeutic effect of exercise. About the Guest Sten Stray Gunderson is an assistant professor at the University of South Carolina, where he researches hypoxia, exercise physiology, and blood flow restriction training. Blood flow restriction runs in his family: his father, Dr. Jim Stray Gunderson, helped pioneer the field and developed Be Strong, the only BFR cuff built by a medical doctor. Sten currently works with a collegiate track and field program and continues to use BFR in...

    Build Muscle, Increase Strength, & Improve Recovery | Blood Flow Restriction Exercise
  7. Jul 28

    You Can Lower Your Alzheimer's Risk, Even With the APOE4 Gene | Dr. Peter McCullough

    If this show helps you, the single best thing you can do is subscribe on YouTube or follow on Apple Podcasts or Spotify. It takes about three seconds and it is the biggest thing that helps the show reach more people. And if you have a moment on Apple Podcasts, a review is a real gift. This episode is a little different. Instead of hosting, Dr. Ravi Kumar was the guest, sitting down with Dr. Peter McCullough on the McCullough Report to talk about Alzheimer's and cognitive decline. Both of Dr. McCullough's parents lived with Alzheimer's, so this one is personal, and it turned into one of Ravi's favorite conversations on the subject, so he brought it home to share here. They get into how common cognitive decline really becomes with age, the new blood tests that can catch it before symptoms ever show up, the truth about APOE4 and why your genes are not your destiny, and the diet and lifestyle factors that actually move the needle. The theme throughout is simple and hopeful: most of what protects your brain costs nothing, and you can start today. In this episode, you will discover How common cognitive decline becomes with age, and what the numbers really look likeWhy the brain makes amyloid your whole life, and why drugs that clear it have mostly failedThe idea of super agers, and why studying success may matter more than studying diseaseWhy prevention, not reversal, is where the strongest evidence liesThe single biggest modifiable risk factor: metabolic health and insulin resistanceWhy walking, especially outdoors in the sunlight, is so protective for the brainHow deep sleep flushes amyloid out of the brain through the glymphatic systemWhy even one night of poor sleep raises amyloid, and how alcohol wrecks sleepHearing loss as one of the largest and most fixable dementia risk factorsWhat APOE4 is, why e4/e4 carries a much higher lifetime risk, and why lifestyle can override itThe new blood tests that can detect Alzheimer's before symptoms appearWhat the approved drugs actually do, and the bleeding risk with anti-amyloid antibodiesThe supplements worth knowing about: vitamin D, magnesium, and CoQ10Why the statin and cognition story is more nuanced than the headlines suggestKey Takeaways Alzheimer's is not a fixed fate written by your genes. Even with a higher-risk variant like APOE4, the daily choices you stack on top of your genetics do an enormous amount to shape where you end up, and most of what protects the brain costs nothing. The strongest levers are metabolic health, daily walking (ideally outdoors and in the sunlight), deep and protected sleep, resistance training, avoiding alcohol, and correcting hearing loss. New blood tests can now flag the disease process years before symptoms, which turns prevention into something you can act on early. The approved drugs remain largely symptomatic, and the amyloid-clearing antibodies carry real bleeding risks, so the center of gravity is shifting toward prevention and risk-factor control. About the Host Dr. Peter McCullough is an internist and cardiologist and the host of the McCullough Report. Both of his parents lived with Alzheimer's disease, which makes cognitive decline one of the medical topics closest to his heart. Resources The Dr. Kumar DiscoveryDr. Ravi Kumar on LinkedInThe McCullough ReportDisclaimer: Dr. McCullough and Dr. Kumar are doctors, but they are not your doctor. This show is for informational purposes only. Take what you learn here, ask better questions, and work with your own doctor. This show is also separate from Dr. Kumar's role as assistant professor at UNC.

    You Can Lower Your Alzheimer's Risk, Even With the APOE4 Gene | Dr. Peter McCullough
  8. Jul 21

    The Prediabetes Warning Sign Your Doctor Isn't Testing For | Dr. Keith Berkowitz

    Struggling with energy crashes, brain fog, or "hangry" meltdowns after you eat? The tool Dr. Kumar and Dr. Berkowitz discuss in this episode, Clarity Blood Sugar, is built to help you figure out what is actually going on with your metabolic health and walk into your doctor's office prepared. Check it out here: https://bloodsugar.claritytx.ai Most people have never heard of reactive hypoglycemia, and many physicians haven't either. But it may affect up to half the population, and it is one of the earliest warning signs on the road to prediabetes and diabetes. In this episode, Dr. Ravi Kumar sits down with Dr. Keith Berkowitz, who worked alongside Dr. Robert Atkins in the late 1990s and became the torch bearer for that whole way of practicing medicine after Atkins passed away. Today Dr. Berkowitz runs the Center for Balanced Health in Manhattan, where he has spent thirty years treating the whole person instead of chasing a single number on a lab report. Together they unpack what reactive hypoglycemia actually is, your blood sugar crashing in the first few hours after you eat, why it leaves you feeling worse instead of better, and how insulin resistance quietly builds for years before glucose ever looks abnormal. Along the way they trace the low-fat era back to its roots, the sugar industry's role in villainizing fat, the gut-brain connection, and why the tools to catch all of this early are finally here. Episode Resources Dr. Keith Berkowitz, Center for Balanced HealthClarity Blood SugarDr. Ravi Kumar on LinkedInDr. Ravi Kumar's WebsiteIn this episode, you will discover What reactive hypoglycemia is, and why up to 50 percent of people may have it without knowingWhy you can feel more tired, foggy, or anxious after eating instead of energizedThe insulin resistance that shows up years, even decades, before glucose ever looks "high"Why it is cortisol, not the low blood sugar itself, that triggers the shakiness, sweating, and racing heartThe everyday clues: vivid dreams, afternoon crashes, "hangry" spells, needing caffeine or sugar to focusHow Dr. Berkowitz's own glucose tolerance test dropped him into the 40s, and what it revealedThe Atkins story: standing against the low-fat craze, and why almost every warning proved rightHow the sugar industry helped villainize fat and eggs, and what the research actually showedWhy digestion, the gut microbiome, and blood sugar are the two foundations of real healthThe simple, evidence-backed way to protect your microbiome when you have to take antibioticsWhy the continuous glucose monitor has been a game changer for catching this earlyHow Clarity Blood Sugar uses human-curated expertise plus AI to validate what you are feeling and build a real planKey Takeaways Reactive hypoglycemia is essentially your blood sugar crashing within a few hours of eating, driven by an inappropriate surge of insulin, and it is one of the earliest predictors of prediabetes and diabetes. The symptoms most people write off, such as fatigue after meals, brain fog, anxiety, vivid dreams, and hangry crashes, are actually your body's cortisol response trying to pull your blood sugar back up. Insulin resistance can build for twenty years before glucose ever looks abnormal on a standard lab, which is why so much of this gets missed. Real metabolic health rests on two foundations: blood sugar and digestion. And the good news is that the biggest levers, including sleep, meal timing, exercise, and easing up on caffeine and alcohol, cost nothing and require no prescription. About the Guest Dr. Keith Berkowitz is the founder and Medical Director of the Center for Balanced Health in Midtown Manhattan, and a founding member of Clarity TX. He trained at Memorial Sloan Kettering and worked directly with Dr. Robert Atkins before carrying that integrative, root-cause philosophy forward into thirty years of his own practice. He sees patients remotely in New York, New Jersey, Florida, and California. Disclaimer: This show is for informational purposes only and is not a substitute for medical advice. Everything shared here is meant to empower you to ask better questions and work with your own doctor. This show is completely separate from Dr. Kumar's role as assistant professor at UNC.

    The Prediabetes Warning Sign Your Doctor Isn't Testing For | Dr. Keith Berkowitz
5
out of 5
91 Ratings

About

Welcome to The Dr. Kumar Discovery, a health and wellness podcast hosted by Dr. Ravi Kumar, a board-certified neurosurgeon. This is the medical podcast for anyone who wants honest, evidence-based answers to the health questions that matter most. No corporate influence. Just a physician who reads the research, questions the dogma, and breaks it down in plain language so you can make better decisions about your own health. Dr. Kumar is a practicing neurosurgeon who brings a surgeon's precision to topics most doctor podcasts only scratch the surface of. Each episode dives deep into the science behind metabolic health, cardiovascular disease, heart disease, hormones, nutrition, brain health, mental health, pain, inflammation, weight loss, aging, blood pressure, sleep, and longevity. Whether it's the truth about seed oils, the real data on GLP-1 drugs and weight loss, the science of cold water therapy, how light can heal the body, or why your testosterone is declining, Dr. Kumar goes straight to the peer-reviewed literature and tells you what the evidence actually shows, not what the headlines say. This is evidence-based medicine in plain English. The show features three formats. Solo deep dives explore a single health topic from the ground up, covering everything from the biology to the practical takeaways you can use today. Expert interviews bring on leading researchers, clinicians, and forward-thinking voices in health and medicine for in-depth conversations you won't hear anywhere else. The Tribulations series tells the true stories behind medicine's greatest breakthroughs, from the discovery of penicillin to the invention of vaccines to a father's fight to save his son's life. These are the stories of the doctors, scientists, and patients who changed the course of medicine. Topics covered on the show include testosterone and hormone optimization, sleep science, photobiomodulation and red light therapy, exercise with oxygen therapy, creatine, uric acid and gout prevention, gut health and probiotics, cardiovascular risk and Lp(a), cholesterol, PANDAS in children, PTSD and trauma, acetaminophen safety, glyphosate, foot health, and much more. If you're tired of generic health advice and want to hear from a neurosurgeon who actually reads the studies, The Dr. Kumar Discovery is your podcast. New episodes drop regularly. Subscribe and join the discovery. For show notes, references, and more, visit drkumardiscovery.com/podcast

You Might Also Like